Affordable Access

Publisher Website

Novel active fixation mechanism permits precise placement with a left ventricular lead: Early results from a multicenter clinical study

Heart Rhythm
DOI: 10.1016/j.hrthm.2014.04.020
  • Lv Lead
  • Lead Dislodgement
  • Biventricular Pacing
  • Active Fixation
  • Left Heart
  • Design
  • Medicine


Background Left ventricular (LV) lead implantation for cardiac resynchronization therapy (CRT) is associated with lead dislodgement rates ranging from 3% to 10%, and some implant approaches to prevent dislodgement may contribute to suboptimal CRT response. We report our early human experience with an LV lead with a side helix for active fixation to the coronary vein wall. Objectives To assess the feasibility and safety of the Model 20066 LV lead and to evaluate the implant procedure. Methods The Model 20066 is a 4-F bipolar steroid eluting lead that has a small exposed side helix and can be delivered using a guidewire or stylet. At the desired vein location, the lead body is rotated clockwise until the helix is fixated. This study was a single-arm, prospective, nonrandomized trial that enrolled 40 patients from 4 centers who met standard indications for CRT. Results The lead was successfully implanted in 39 of 40 (97.5%) patients. In 38 of 40 (95%) patients, the implanters were successful at implanting at a predetermined target site. There were no Model 20066 LV lead dislodgements reported within 12 months of follow-up. The electrical performance of the tip and ring electrodes was stable through the 12-month follow-up visit and similar to other LV leads. Overall lead handling was rated as acceptable for all implants. Conclusion This new LV lead specifically designed with an active fixation mechanism for stability and precise placement was successfully and safely deployed in the coronary vasculature.

There are no comments yet on this publication. Be the first to share your thoughts.